1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Acidity Global Clinical Trials Review, H1, 2017

Acidity Global Clinical Trials Review, H1, 2017

  • February 2017
  • -
  • GlobalData
  • -
  • 47 pages

Acidity Global Clinical Trials Review, H1, 2017

Summary

GlobalData’s clinical trial report, “Acidity Global Clinical Trials Review, H1, 2017" provides an overview of Acidity clinical trials scenario. This report provides top line data relating to the clinical trials on Acidity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

* Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Acidity Global Clinical Trials Review, H1, 2017
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Acidity to Gastrointestinal Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Acidity to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Acidity Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 44
Abbreviations 44
Definitions 44
Research Methodology 45
Secondary Research 45
About GlobalData 46
Contact Us 46
Disclaimer 46
Source 47

List of Tables
Acidity Therapeutics, Global, Clinical Trials by Region, 2017* 5
Acidity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Acidity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Acidity Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 8
Acidity Therapeutics Clinical Trials, Europe, Top Countries, 2017* 9
Acidity Therapeutics Clinical Trials, North America, Top Countries, 2017* 10
Acidity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11
Proportion of Acidity to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 12
Acidity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Acidity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Acidity to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 15
Acidity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 16
Acidity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 17
Acidity Therapeutics, Global, Clinical Trials by Phase, 2017* 18
Acidity Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
Acidity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Acidity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Acidity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Acidity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
Acidity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Acidity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Acidity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26

List of Figures
Acidity Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
Acidity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Acidity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
Acidity Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 8
Acidity Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 9
Acidity Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10
Proportion of Acidity to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 12
Acidity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Acidity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Acidity to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 15
Acidity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 16
Acidity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 17
Acidity Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
Acidity Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
Acidity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Acidity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Acidity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Acidity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
Acidity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Acidity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Acidity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
GlobalData Methodology 45

Companies Mentioned
Dr. Reddy's Laboratories Ltd
Bayer AG
Vimta Labs Ltd
Valeant Pharmaceuticals International Inc
Neutec Ilac San Tic AS
C. H. Boehringer Sohn AG and Co KG
Eisai Co Ltd
AstraZeneca Plc
Aralez Pharmaceuticals Inc
Abbott Laboratories

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.